Envestnet Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Envestnet Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,975	Closed	-$277K	–	4846
2026 Q1	$277K	Buy	+6,975	New	+$178K	﹤0.01%	4320

Envestnet Asset Management's CNTA Position: Q2 2026 in Review

Envestnet Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 6,975 shares — an estimated $277K sold.

Envestnet Asset Management first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $277K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Envestnet Asset Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Envestnet Asset Management sold 6,975 Centessa Pharmaceuticals shares in Q2 2026, an estimated $277K.
Envestnet Asset Management first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Envestnet Asset Management's Centessa Pharmaceuticals position peaked at $277K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.